News

OCRA-Funded Research Moves Immunotherapy Forward

(September 5, 2019) OCRA funded investigator Dmitriy Zamarin, MD, PhD contributed to a study that provides an intriguing hypothesis that mutation in genes like SMARCA4 may improve tumor recognition by the immune system…

Read on

September is Ovarian Cancer Awareness Month

Every September, we come together to shine a spotlight on ovarian cancer, spread awareness, and raise critical funds for research and patient support…

Read on

Should You Be Tested for BRCA Mutations? New Guidelines

(August 22, 2019) This week, The US Preventive Services Task Force published new recommendations on risk assessment, genetic counseling, and genetic testing for BRCA mutations and BRCA-related cancers…

Read on

New Direction for Research: Microbiota

(August 20, 2019) A new direction for research in ovarian cancer was brought to light last month thanks to a study published in Lancet Oncology. Researchers led by Dr. Nuno R…

Read on

BE LOUD Video Series Turns Up the Volume on Ovarian Cancer

(August 21, 2019) Every 23 minutes, another woman in the U.S. hears the words “You have ovarian cancer” for the first time. Because ovarian cancer symptoms can be subtle and attributed to other factors, diagnosis often comes as a surprise…

Read on

OCRA Funded Research Reveals New Drug Therapy Combination

(July 26, 2019) OCRA grantee Michael Yaffe, MD, PhD, led a study published earlier this month in Cell Systems which found success targeting cancer cells by combining two existing classes of drugs. Dr…

Read on

Watch OCRA’s 2019 National Conference Presentations on Live Stream

Couldn’t make it to our National Conference? Watch our expert presentations LIVE! For the first time, we live streamed all general sessions, so you can watch as our expert speakers present the latest ovarian cancer updates, from wherever you…

Read on

An Interview With President & CEO Audra Moran

(June 19, 2019) In an interview with SurvivorNet, OCRA President and CEO Audra Moran offers some guidance to women who are battling ovarian cancer: #1 – You don’t need to go through it alone…

Read on

Combination Niraparib plus Pembrolizumab Shows Promise

(June 18, 2019) Results of new trials, funded in part by OCRA though the Ovarian Cancer Dream Team and published in JAMA Oncology, show that combination niraparib plus pembrolizumab therapy showed promising antitumor activity in patients with…

Read on

OCRA and American Cancer Society Launch New Ovarian Cancer Research Collaboration

Four multidisciplinary teams to be funded to study survivorship (June 13, 2019) In a new collaboration, the American Cancer Society and Ovarian Cancer Research Alliance have joined forces to fund multidisciplinary research projects to explore new…

Read on

View the Agenda for OCRA’s Ovarian Cancer National Conference

Don’t miss a weekend packed with information and inspiration, July 12-14 in Seattle, Washington! View a print-friendly version of our agenda…

Read on

Highlights from American Society of Clinical Oncology’s Annual Meeting

(June 7, 2019) OCRA is back from the American Society of Clinical Oncology’s annual meeting in Chicago, where doctors and researchers met to discuss the latest in the care of women with ovarian cancer…

Read on